Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Knowgene

Explore full profile

Cancer genetics knowledge assessment for multigene panel testing

ChinaFounded 2007eCommerce & Marketplaces
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Knowgene and the history behind them.

About Knowgene

KnowGene is a validated scale designed to measure a patient's knowledge regarding cancer genetics, specifically in the context of multigene panel testing (MGPT). Developed through systematic input from genetics experts and evaluated by patient advocates, the tool is used to assess the effectiveness of genetic counseling. The scale consists of a series of items with "true," "false," or "don't know" response options, where "don't know" is scored as incorrect.

The development and validation of the KnowGene scale was led by researchers from institutions including the Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Simmons College. It addresses a critical need in clinical practice and research to systematically measure patient understanding after undergoing genetic counseling for hereditary cancer risks. This allows healthcare providers and researchers to inform and improve practice initiatives in the field of cancer genetics.

KnowGene is utilized in studies to evaluate patient outcomes, such as the psychosocial impact of genetic counseling and testing for individuals with various cancers, including ovarian and prostate cancer. The scale helps in understanding the effectiveness of different educational interventions, such as pretest video education versus traditional genetic counseling.

Source: Dealroom company data

At a glance

Founded
2007
Headquarters
China
Sector
eCommerce & Marketplaces

Investors

14 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • Olympus Capital Holdings Asia
  • Abax Global Capital

Series A8 investors entered at this stage

  • YunFeng Capital
  • China Everbright Limited
  • Ronglian
  • Shenzhen Capital Group
  • SB China Capital
  • Greenwoods Asset Management
  • Kaiwu Capital
  • GuoHe Capital

Series B and later4 investors entered at this stage

  • Guosen H&S Investments
  • Gaolin Capital
  • Huaxia Life Insurance
  • NLVC
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Knowgene on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Knowgene on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.